Zusammenfassung
Die Zuordnung einer Demenzerkrankung zu einem neurodegenerativen Pathomechanismus, wie der Demenz vom Alzheimer-Typ (DAT) oder einem vaskulären Pathomechanismus, kann trotz der Verfügbarkeit bildgebender Verfahren Probleme bereiten. Überlappungen neurodegenerativer und vaskulärer Mechanismen sind häufig. Mikroangiopathische Veränderungen des Marklagers finden sich bei einem hohen Anteil von Patienten mit der klinischen Verlaufsform einer Demenz vom Alzheimer-Typ. Es ist unklar, ob es sich um eine Koinzidenz zweier Pathomechanismen handelt oder ob eine wechselseitige Beeinflussung stattfindet. Die hohe Sensitivität der Magnetresonanztomographie bei der Erfassung mikroangiopathischer Veränderungen des Marklagers könnte dazu führen, dass zu vaskuläre Demenzerkrankungen häufig diagnostiziert werden. Der Einfluss mikroangiopathischer Veränderungen des Marklagers auf den Demenzverlauf wird kontrovers diskutiert. Die vorgelegte Arbeit gibt eine Übersicht über die aktuellen Konzepte zum Stellenwert von Marklagerveränderungen bei Demenzerkrankungen.
Abstract
Due to a significant overlap of the two syndromes, differentiation of degenerative dementia of the Alzheimer-type from vascular dementia may be difficult even when imaging studies are available. White matter changes occur in many patients suffering from Alzheimer's disease.
Little is known about the impact of white matter changes on the course and clinical presentation of Alzheimer's disease. High sensitivity of MRI in the detection of white matter alterations may account for over-diagnosing vascular dementia. The clinical significance of white matter alterations in dementia is still a matter of debate. The article reviews current concepts about the role of white matter alterations in dementia.
Literatur
Baum KA, Schulte C, Girke W, Reischies FM, Felix R (1996) Incidental white-matter foci on MRI in "healthy" subjects: evidence of subtle cognitive dysfunction. Neuroradiology 38:755–760
Babikian V, Ropper AH (1987) Binswanger´s disease: a review. Stroke 18:2–12
Bischoff C, Gräfin von Einsiedel H (1997) Bedeutung der Leukoaraiosis. Eine Bestandsaufnahme und differentialdiagnostische Abgrenzung. Nervenarzt 68:609–619
Bowler JV, Munoz DG, Merskey H, Hachinski VC (1998) Fallacies in the pathological confirmation of the diagnosis of Alzheimer´s disease. J Neurol Neurosurg Psychiatry 64:18–24
Bowler JV (2002) The concept of vascular cognitive impairment. J Neurol Sci 203/204:11–15
Breteler MMB, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JHW, van Harskamp F, Tanghe HLJ, de Jong PTVM, van Gijn J, Hofman A (1994) Cerebral white matter lesions, vascular risk factors and cognitive function in a population-based study: the Rotterdam study. Neurology 44:1246–1252
Bronge L, Wahlund LO (2003) Prognostic significance of white matter changes in a memory clinic population. Psychiatry Res Neuroimaging 122:199–206
Canadian Study of Health and Aging Working Group (1994) The Canadian study of health and aging: study methods and prevalence of dementia. Can Med Assoc J 150:899–913
Caplan LR (1995) Binswanger´s disease—revisited. Neurology 45:626–633
De la Torre JC (2002) Vascular basis of Alzheimer´s pathogenesis. Ann N Y Acad Sci 977:196–215
Dufouil C, Alpérovitch A, Tzourio C (2003) Influence of education on the relationship between white matter lesions and cognition. Neurology 60:831–836
Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmermann RA (1987) MR signal abnormalities at 1.5 T in Alzheimer´s dementia and normal aging. Am J Neuroradiol 8:421–426
Fazekas F, Schmidt R, Scheltens P (1998) Pathophysiologic mechanisms in the development of age-realted white matter changes of the brain. Dement Geriatr Cogn Disord 9 [suppl 1]:2–5
Fein G, van Dyke C, Davenport L, Turetsky B, Brant-Zawadzki M, Zatz L, Dillon W, Valk P (1990) Preservation of normal cognitive functioning in elderly subjects with extensive white-matter lesions of long duration. Arch Gen Psychiatry 47:220–223
Gertz HJ, Wolf H, Arendt T (2002) Vaskuläre Demenz. Nervenarzt 73:393–404
Hachinski VC, Potter P, Merkey H (1987) Leuko-Araiosis. Arch Neurol 44:21–23
Hentschel F, Kreis M, Damian M, Krumm B (2003) Mikroangiopathische Läsionen der weißen Hirnsubstanz. Nervenarzt 74:355–361
Hirono N, Kitagaki H, Kazui H, Hashimoto M, Mori E (2000) Impact of white matter changes on clinical manifestation of Alzheimer´s disease. Stroke 31:2182–2188
Hunt AL, Orrison WW, Yeo RA, Haaland KY, Rhyne RL, Garry PJ, Rosenberg GA (1989) Neurology 39:1470–1474
Jellinger KA (2002) Vascular-ischemic dementia: an update. J Neural Transm 62 [suppl]:1–23
Kalaria R (2002) Similarities between Alzheimer´s disease and vascular dementia. J Neurol Sci 203/204:29–34
Kapeller P, Schmidt R (1998) Concepts on the prognostic significance of white matter changes. J Neural Transm 53 [suppl]:69–78
Kloß T, Maleßa R, Weiller C, Diener HC (1994) Vaskuläre Demenz im Wandel—eine Übersicht zur vaskulären Demenz von zurückliegenden zu neuen Konzepten. Fortschr Neurol Psychiat 62:197–219
Knopman DS, Parisi JE, Boeve BF, Cha RH, Apaydin H, Salviati A, Edland SD, Rocca WA (2003) Vascular dementia in a population-based autopsy study. Arch Neurol 60:569–575
Kono I, Mori S, Nakajima K, Kizu O, Yamada K, Sakai Y (2000) Clinical significance of white matter changes in senile dementia of the Alzheimer type. Ann N Y Acad Sci 977:430–435
Korczyn AD (2002) The complex nosological concept of vascular dementia. J Neurol Sci 203/204:3–6
Longstreth WT, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O´Leary D, Fried L (1996) Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. Stroke 27:1274–1282
Matsubayashi K, Shimada K, Kawamoto A, Ozawa T (1992) Incidental brain lesions on magnetic resonance imaging and neurobehavioral functions in the apparently healthy elderly. Stroke 23:175–180
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan M (1984) Clinical diagnosis of Alzheimer´s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer´s disease. Neurology 34:939–944
Merino JG, Hachinski V (2000) Leukoaraiosis. Editorial. Arch Neurol 57:925–926
Mori E (2002) Impact of subcortical ischemic lesions on behavior and cognition. Ann N Y Acad Sci 977:141–148
Ott A, Breteler MMB, van Harskamp F, Claus JJ, van der Cammen TJM, Grobbee DE, Hofman A (1995) Prevalence of Alzheimer´s disease and vascular dementia: association with education. The Rotterdam study. Brit Med J 310:970–973
Pantoni L, Garcia J (1997) Pathogenesis of leukoaraiosis: a review. Stroke 28:652–659
Pohjasvaara T, Mäntylä R, Ylikosky R, Kaste M, Erkinjuntti T (2000) Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. Stroke 31:2952–2957
Román GC, Tatemichi TK, Erkinjuntti T et al. (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43:250–260
Sabri O, Ringelstein EB, Hellwig D, Schneider R, Schreckenberger M, Kaiser HJ, Mull M, Buell U (1999) Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy. Stroke 30:556–566
Scheltens P, Barkhof F, Leyes D, Wolters EC, Ravid R, Kamphorst W (1995) Histopathologic correlates of white matter changes on MRI in Alzheimer´s disease and normal aging. Neurology 45:883–888
Scheltens P, Erkinjuntti T, Leys D, Wahlund LO, Inzitari D, delSer T, Pasquier F, Barkhof F, Mäntylä R, Bowler J, Wallin A, Ghika J, Fazekas F, Pantoni L (1998) White matter changes on CT and MRI: an overview of visual rating scales. Eur Neurol 39:80–89
Schmidt R, Fazekas F, Kapeller P, Schmidt H, Hartung HP (1999) MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study. Neurology 53:132–139
Schmidt R, Schmidt H, Kapeller P, Enzinger C, Ropele S, Saurugg R, Fazekas F (2002) The natural course of MRI white matter hyperintensities. J Neurol Sci 203/204:253–257
Smith CD, Snowdon DA, Wang H, Merkesbery WR (2000) White matter volumes and periventricular white matter hyperintensities in aging and dementia. Neurology 54:838–842
Steingart A, Hachinski VC, Lau C, Fox AJ, Diaz F, Cape R, Lee D, Inzitari D, Merskey H (1987) Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (Leuko-Araiosis). Arch Neurol 44:32–35
Stoppe G, Staedt J, Bruhn H (1995) Fleckige Veränderungen der weißen Substanz im kranialen Computer- und Magnetresonanztomogramm—Bedeutung für die (Differential-) Diagnose der Demenz vom Alzheimer-Typ und der vaskulären Demenz. Fortschr Neurol Psychiat 63:425–440
Stoppe G, Bruhn H, Finkenstaedt M, Meller J, Becker W (2000) Hirnleistungsstörungen und Demenzen. In: Stoppe G, Hentschel F, Munz DL (Hrsg) Bildgebende Verfahren in der Psychiatrie. Thieme, Stuttgart
Van Swieten JC, Geyskes GG, Derix MA, Peeck BM, Ramos LMP, van Latum JC, van Gijn J (1991) Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol 30:825–830
Wahlund LO, Basun H, Almkvist O, Andersson-Lundman G, Julin P, Sääf J (1994) White matter hyperintensities in dementia: does it matter? Magn Reson Imaging 12:387–394
Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, Ohmori S, Nomiyama K, Kawano H, Ueda K et al. (1995) Incidence and risk factors of vascular dementia and Alzheimer´s disease in a defined elderly Japanese population: the Hisayama study. Neurology 45:1161–1168
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Supprian, T., Kessler, H., Retz, W. et al. Marklagerveränderungen bei neurodegenerativen und vaskulären Demenzerkrankungen. Radiologe 43, 543–551 (2003). https://doi.org/10.1007/s00117-003-0916-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00117-003-0916-5